Intensive glucose therapy improves some markers

04/25/2013 | Healio

Older type 2 diabetes patients who underwent intensive glucose-lowering therapy attained better adiponectin, lipid and triglyceride levels at nine months, a study indicated. However, the intensive therapy did not appear to improve cardiovascular outcomes in patients, researchers reported in Diabetes Care.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX